Literature DB >> 15582123

Processing of protein glycation, oxidation and nitrosation adducts in the liver and the effect of cirrhosis.

Naila Ahmed1, Paul J Thornalley, Reinhard Lüthen, Dieter Häussinger, Katarina Sebekova, Reinhard Schinzel, Wolfram Voelker, August Heidland.   

Abstract

BACKGROUND/AIMS: Plasma proteins are modified non-enzymatically in vivo by glycation, oxidation and nitrosation processes. Hepatic extraction of albumin glycated in vitro was reported but it is not clear if plasma proteins glycated in vivo also undergo hepatic extraction. We investigated the hepatic extraction of glycated, oxidised and nitrosated proteins in vivo.
METHODS: Protein glycation, oxidation and nitrosation marker residues and free adducts were determined in portal, hepatic and peripheral venous blood plasma of cirrhotic patients and hepatic and peripheral venous blood plasma (as a surrogate of portal venous blood) of control subjects by liquid chromatography-mass spectrometry.
RESULTS: There was no evidence for extraction of glycated, oxidised or nitrosated proteins or related free adducts by the liver in control subjects. There was limited extraction of methylglyoxal-modified proteins in cirrhotic patients and twofold increases in the concentrations of fructosyl-lysine and advanced glycation endproduct residues of plasma protein, with respect to controls. Remarkably, glyoxal-derived hydroimidazolone free adduct was increased 14-16-fold probably as a consequence of hepatic lipid peroxidation.
CONCLUSIONS: We found no evidence for hepatic extraction of glycated, oxidised and nitrosated proteins or related free adducts in subjects with normal liver function and limited extraction of methylglyoxal-modified protein in cirrhotic subjects.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15582123     DOI: 10.1016/j.jhep.2004.08.007

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  18 in total

1.  Increased protein damage in renal glomeruli, retina, nerve, plasma and urine and its prevention by thiamine and benfotiamine therapy in a rat model of diabetes.

Authors:  N Karachalias; R Babaei-Jadidi; N Rabbani; P J Thornalley
Journal:  Diabetologia       Date:  2010-04-06       Impact factor: 10.122

Review 2.  Glycation free adduct accumulation in renal disease: the new AGE.

Authors:  Paul J Thornalley
Journal:  Pediatr Nephrol       Date:  2005-08-24       Impact factor: 3.714

3.  Degradation products of proteins damaged by glycation, oxidation and nitration in clinical type 1 diabetes.

Authors:  N Ahmed; R Babaei-Jadidi; S K Howell; P J Beisswenger; P J Thornalley
Journal:  Diabetologia       Date:  2005-06-30       Impact factor: 10.122

Review 4.  Methylglyoxal and Its Adducts: Induction, Repair, and Association with Disease.

Authors:  Seigmund Wai Tsuen Lai; Edwin De Jesus Lopez Gonzalez; Tala Zoukari; Priscilla Ki; Sarah C Shuck
Journal:  Chem Res Toxicol       Date:  2022-10-05       Impact factor: 3.973

Review 5.  Mechanisms of Diabetes-Induced Liver Damage: The role of oxidative stress and inflammation.

Authors:  Jamaludin Mohamed; A H Nazratun Nafizah; A H Zariyantey; S B Budin
Journal:  Sultan Qaboos Univ Med J       Date:  2016-05-15

Review 6.  Protein and nucleotide damage by glyoxal and methylglyoxal in physiological systems--role in ageing and disease.

Authors:  Paul J Thornalley
Journal:  Drug Metabol Drug Interact       Date:  2008

7.  Serum levels of advanced glycation endproducts and other markers of protein damage in early diabetic nephropathy in type 1 diabetes.

Authors:  Bruce A Perkins; Naila Rabbani; Andrew Weston; Linda H Ficociello; Antonysunil Adaikalakoteswari; Monika Niewczas; James Warram; Andrzej S Krolewski; Paul Thornalley
Journal:  PLoS One       Date:  2012-04-25       Impact factor: 3.240

8.  Alpha-synuclein deficiency leads to increased glyoxalase I expression and glycation stress.

Authors:  Alexander Kurz; Naila Rabbani; Michael Walter; Michael Bonin; Paul Thornalley; Georg Auburger; Suzana Gispert
Journal:  Cell Mol Life Sci       Date:  2010-08-14       Impact factor: 9.261

9.  Skin intrinsic fluorescence is associated with coronary artery disease in individuals with long duration of type 1 diabetes.

Authors:  Baqiyyah N Conway; Vanita R Aroda; John D Maynard; Nathaniel Matter; Stephen Fernandez; Robert E Ratner; Trevor J Orchard
Journal:  Diabetes Care       Date:  2012-07-30       Impact factor: 19.112

10.  Unchanged serum levels of advanced glycation endproducts in patients with liver disease.

Authors:  Moritz Butscheid; Christian Schäfer; Stefanie Brenner; Dominik Alscher; Thomas Mürdter; Toshimitsu Niwa; Matthias Frischmann; Monika Pischetsrieder; Ulrich Klotz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-06-15       Impact factor: 3.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.